Literature DB >> 30970512

Human telomerase reverse transcriptase recruits the β-catenin/TCF-4 complex to transactivate chemokine (C-C motif) ligand 2 expression in colorectal cancer.

Siyuan Chen1, Li Yang1, Hui Dong1, Hong Guo2.   

Abstract

BACKGROUND AND AIM: Various molecular mechanisms are involved in the pathogenesis of colorectal cancer (CRC), one of the leading fatal diseases. Although human telomerase reverse transcriptase (hTERT) is critical in promoting CRC development, its regulatory mechanism is still elusive. Chemokine (C-C motif) ligand 2 (CCL2) is important to CRC pathogenesis, but the upstream regulation of CCL2 requires further investigation. Therefore, we aim to investigate the crosstalk mechanism between hTERT and CCL2 and its involvement in the pathogenesis of CRC.
METHODS: The expression relationship between hTERT and CCL2 was verified in CRC and adjacent tissues by immunohistochemistry. Lentiviruses or plasmids were used to regulate hTERT and CCL2 expression. The roles of hTERT and CCL2 in cell growth and migration were studied using CCK8 and transwell assays. The interaction between hTERT and CCL2 was detected by a luciferase reporter assay, immunofluorescence and ChIP assays. The β-catenin/TCF-4 complex was confirmed by COIP.
RESULTS: Both hTERT and CCL2 expression levels were markedly increased in CRC tissues compared to the adjacent stroma. Moreover, myeloid-derived suppressor cells (MDSCs) were found in tumor areas with higher expression levels of hTERT and CCL2. hTERT promoted HCT116 cell migration and invasion by increasing CCL2 expression. Mechanistically, ectopic hTERT facilitated the nuclear translocation of canonical β-catenin and the formation of a complex with downstream effector TCF-4, which eventually activated the CCL2 promoter.
CONCLUSIONS: hTERT may promote CRC by recruiting β-catenin/TCF-4 complex to transactivate CCL2 expression, which is a novel crosstalk mechanism likely involved in the pathogenesis of CRC.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Chemokine (C-C motif) ligand 2; Human telomerase reverse transcriptase; Metastasis; Tumor promotion; Wnt signaling pathway

Mesh:

Substances:

Year:  2019        PMID: 30970512     DOI: 10.1016/j.biopha.2019.108700

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  4 in total

1.  Crosstalk between β-Catenin and CCL2 Drives Migration of Monocytes towards Glioblastoma Cells.

Authors:  Philippe Aretz; Donata Maciaczyk; Suad Yusuf; Rüdiger V Sorg; Daniel Hänggi; Hongjia Liu; Hongde Liu; Tikam Chand Dakal; Amit Sharma; Ramakrishna Bethanabatla; Silke Neumann; Jarek Maciaczyk
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

2.  Telomerase activation in the treatment of aging or degenerative diseases: a systematic review.

Authors:  P Prieto-Oliveira
Journal:  Mol Cell Biochem       Date:  2020-10-01       Impact factor: 3.396

3.  M2 macrophages reduce the effect of gefitinib by activating AKT/mTOR in gefitinib-resistant cell lines HCC827/GR.

Authors:  Fengqi Xiao; Ni Liu; Xinchun Ma; Jing Qin; Yanguo Liu; Xiuwen Wang
Journal:  Thorac Cancer       Date:  2020-09-21       Impact factor: 3.500

Review 4.  Implications of telomerase reverse transcriptase in tumor metastasis.

Authors:  Yongkang Zou; Yu-Sheng Cong; Junzhi Zhou
Journal:  BMB Rep       Date:  2020-09       Impact factor: 4.778

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.